TARGETING TUMOUR NECROSIS FACTOR ALPHA

This publication has 144 references indexed in Scilit:

• Keratinocyte-Derived Chemotactic Cytokines: Expressional Modulation by Nitric Oxide in Vitro and during Cutaneous Wound Repair in Vivo
  Biochemical and Biophysical Research Communications, 2000
• Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions
  Journal of the American Academy of Dermatology, 2000
• Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
  New England Journal of Medicine, 1999
• Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
  New England Journal of Medicine, 1999
• Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
  Published by Elsevier ,1999
• Ultraviolet-B-Induced Apoptosis of Keratinocytes: Evidence for Partial Involvement of Tumor Necrosis Factor-α in the Formation of Sunburn Cells
  Journal of Investigative Dermatology, 1995
• The treatment of microsporidial diarrhoea with thalidomide
  AIDS, 1995
• Thalidomide is an inhibitor of angiogenesis.
  Proceedings of the National Academy of Sciences, 1994
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
  The Journal of Experimental Medicine, 1993
• Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor.
  Journal of Clinical Investigation, 1986